11.28.2016 - By Clarivate Analytics – Formerly the IP&Science business of Thomson Reuters
The Cancer Moonshot Initiative is intended to accelerate the pace of cancer research. The field of cancer immunotherapy presents real promise for cancer patients – offering a less toxic treatment protocol that reduces their suffering. Amy Braden, a Solutions Specialist at Clarivate Analytics, provides an analysis of her investigation of the landscape of cancer immunotherapy research. Her report examines the outputs from organizations and institutions that are having the biggest impacts in this area and provides a starting point from which to ask informed questions about immunotherapy research.